Compounds > resveratrol
Page last updated: 2024-08-16

resveratrol and fosbretabulin

resveratrol has been researched along with fosbretabulin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chapuis, JC; Grealish, MP; Hamel, E; Jung, MK; Pettit, GR; Pettit, RK; Schmidt, JM1
Chapuis, JC; Hamel, E; Hogan, F; Moser, BR; Pettit, GR; Pettit, RK; Pon, S; Schmidt, JM; Wolf, S1
Groy, TL; Herald, CL; Knight, JC; Melody, N; Pettit, GR; Thornhill, A1
Colin, D; Delmas, D; Fasseur, D; Gobbo, J; Latruffe, N; Mazué, F; Meunier, P; Rescifina, A; Spatafora, C; Tringali, C; Wegner, M1
Lu, X; Ruan, BF; Tang, JF; Wang, LS; Wang, XL; Wei, Y; Zhang, YB; Zhu, HL1
Hong, Y; Kong, LD; Li, Z; Liu, L; Liu, YL; Shi, YW; Wang, CP; Wang, X1

Other Studies

6 other study(ies) available for resveratrol and fosbretabulin

ArticleYear
Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate.
    Journal of medicinal chemistry, 2002, Jun-06, Volume: 45, Issue:12

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Bacteria; Biopolymers; Cell Division; Drug Screening Assays, Antitumor; Fungi; Humans; Microbial Sensitivity Tests; Organophosphates; Prodrugs; Resveratrol; Stereoisomerism; Stilbenes; Structure-Activity Relationship; Tubulin; Tumor Cells, Cultured

2002
E-Combretastatin and E-resveratrol structural modifications: antimicrobial and cancer cell growth inhibitory beta-E-nitrostyrenes.
    Bioorganic & medicinal chemistry, 2009, Sep-15, Volume: 17, Issue:18

    Topics: Anti-Infective Agents; Antineoplastic Agents; Bacteria; Bibenzyls; Cell Line, Tumor; Cell Proliferation; Fungi; Humans; Molecular Structure; Resveratrol; Stilbenes; Structure-Activity Relationship; Styrenes; Tubulin; Tubulin Modulators

2009
Antineoplastic agents. 579. Synthesis and cancer cell growth evaluation of E-stilstatin 3: a resveratrol structural modification.
    Journal of natural products, 2009, Volume: 72, Issue:9

    Topics: Antineoplastic Agents; Bibenzyls; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Molecular Conformation; Molecular Structure; Prodrugs; Resveratrol; Stereoisomerism; Stilbenes; Structure-Activity Relationship

2009
Structural determinants of resveratrol for cell proliferation inhibition potency: experimental and docking studies of new analogs.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:7

    Topics: Binding Sites; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colchicine; DNA; Humans; Hydroxides; Models, Molecular; Resveratrol; Stereoisomerism; Stilbenes; Tubulin

2010
Synthesis, biological evaluation, and molecular docking studies of resveratrol derivatives possessing chalcone moiety as potential antitubulin agents.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Binding Sites; Cell Line, Tumor; Chalcone; Dose-Response Relationship, Drug; Humans; Protein Binding; Resveratrol; Stilbenes; Structure-Activity Relationship; Tubulin Modulators

2011
Antihyperuricemic and nephroprotective effects of resveratrol and its analogues in hyperuricemic mice.
    Molecular nutrition & food research, 2012, Volume: 56, Issue:9

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Blood Urea Nitrogen; Carrier Proteins; Creatinine; Disaccharides; Gene Expression Regulation; Glucose Transport Proteins, Facilitative; Glucosides; Gout Suppressants; Hyperuricemia; Kidney; Male; Membrane Proteins; Mice; Mice, Inbred Strains; Octamer Transcription Factor-1; Organic Anion Transport Protein 1; Organic Anion Transporters; Organic Cation Transport Proteins; Organic Cation Transporter 2; Oxonic Acid; Resveratrol; Solute Carrier Family 22 Member 5; Stilbenes; Symporters; Uric Acid

2012